
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Boston Scientific has announced a definitive agreement to acquire SoniVie Ltd., a privately held medical device company specializing in ultrasound-based therapies for hypertension. The deal, valued at up to $540 million, will add SoniVie's TIVUS …